Regardless of whether I agree or disagree with Mr. Huney's article, I have to say I am shocked that he has a venue. Does this mean that any recent grad can blog away and have his relatively unqualified opinion front and center on Yahoo? I mean, come on......
Sort by:
Latest | Highest ratedBuy Hemispherix Before Ampligen's FDA Approval [View article]
Hemispherx Biopharma: Hot and Likely to Get Hotter [View article]
The Vocus Conundrum [View article]